Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.

[1]  S. Hay,et al.  Cause-specific mortality by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities , 2023, The Lancet.

[2]  G. Cholankeril,et al.  Trends in mortality of liver cancer before and during the COVID‐19 pandemic, 2017–2021 , 2023, Liver international : official journal of the International Association for the Study of the Liver.

[3]  Hongyu Meng,et al.  Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database , 2023, Journal of gastrointestinal oncology.

[4]  T. Meyer,et al.  Hepatocellular carcinoma , 2022, The Lancet.

[5]  M. Borad,et al.  Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017 , 2022, The oncologist.

[6]  H. El‐Serag,et al.  Neighborhood-level factors contribute to disparities in hepatocellular carcinoma incidence in Texas. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  Christopher J. L. Murray,et al.  Life expectancy by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities , 2022, The Lancet.

[8]  Noele P. Nelson,et al.  Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[9]  R. Feldman,et al.  Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries , 2022, PloS one.

[10]  Xiaoxiao Sun,et al.  Advancing Liver Cancer Prevention for American Indian Populations in Arizona: An Integrative Review , 2022, International journal of environmental research and public health.

[11]  B. McMahon,et al.  Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992–2018 , 2022, Hepatology.

[12]  Yanning Liu,et al.  Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study , 2022, Cancer control : journal of the Moffitt Cancer Center.

[13]  Vijay Kumar Chattu,et al.  Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 , 2021, JAMA oncology.

[14]  J. Bruix,et al.  BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. , 2021, Journal of hepatology.

[15]  S. J. Henley,et al.  Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017 , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[16]  Shelly C. Lu,et al.  The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States. , 2021, Journal of the National Cancer Institute.

[17]  Po‐Hong Liu,et al.  Comparison of Hepatocellular Carcinoma in Hispanic and Non-Hispanic Patients , 2021, Cureus.

[18]  D. Goldberg,et al.  County Differences in Liver Mortality in the US: Impact of Sociodemographics, Disease Risk Factors, and Access to Care. , 2020, Gastroenterology.

[19]  Navid Rabiee,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[20]  M. Wagner,et al.  New frontiers in liver resection for hepatocellular carcinoma , 2020, JHEP reports : innovation in hepatology.

[21]  Yulei N. Wang,et al.  Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. , 2020, The New England journal of medicine.

[22]  A. Lok,et al.  Chronic Hepatitis B Prevalence Among Foreign‐Born and U.S.‐Born Adults in the United States, 1999‐2016 , 2020, Hepatology.

[23]  D. Kanny,et al.  Trends in Total Binge Drinks per Adult Who Reported Binge Drinking — United States, 2011–2017 , 2020, MMWR. Morbidity and mortality weekly report.

[24]  Jessica L. Barrett,et al.  Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. , 2019, The New England journal of medicine.

[25]  R. Bataller,et al.  Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century. , 2019, The American journal of gastroenterology.

[26]  A. Ejaz,et al.  Intrahepatic Cholangiocarcinoma. , 2019, Surgical oncology clinics of North America.

[27]  Purushottam W. Laud,et al.  Racial disparities of liver cancer mortality in Wisconsin , 2019, Cancer Causes & Control.

[28]  Chenchen Xie,et al.  Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? , 2019, Translational gastroenterology and hepatology.

[29]  O. Adegbala,et al.  Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States , 2019, Annals of gastroenterology.

[30]  E. Kobetz,et al.  Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity , 2019, JHEP reports.

[31]  J. Marrero,et al.  Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  A. Suk-Fong Lok Hepatitis B Treatment: What We Know Now and What Remains to Be Researched , 2018, Hepatology communications.

[33]  Andrew A. Li,et al.  Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016 , 2018, Journal of viral hepatitis.

[34]  E. Tapper,et al.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study , 2018, British Medical Journal.

[35]  Jiaquan Xu Trends in Liver Cancer Mortality Among Adults Aged 25 and Over in the United States, 2000-2016. , 2018, NCHS data brief.

[36]  T. Asselah,et al.  Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure? , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[37]  H. Weir,et al.  Liver cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study , 2017, Cancer.

[38]  D. Goldberg,et al.  Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End‐Stage Liver Disease Patients , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  A. Jemal,et al.  Disparities in liver cancer occurrence in the United States by race/ethnicity and state , 2017, CA: a cancer journal for clinicians.

[40]  Rebecca W. Stubbs,et al.  Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014 , 2017, JAMA.

[41]  V. Rapisarda,et al.  Non-infective occupational risk factors for hepatocellular carcinoma: A review , 2016, Molecular medicine reports.

[42]  Mohsen Naghavi,et al.  US County-Level Trends in Mortality Rates for Major Causes of Death, 1980-2014. , 2016, JAMA.

[43]  Gretchen A. Stevens,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, The Lancet.

[44]  Noele P. Nelson,et al.  Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. , 2016, Clinics in liver disease.

[45]  R. Gish,et al.  Race/ethnicity‐specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States , 2016, Cancer.

[46]  B. Graubard,et al.  Population attributable fractions of risk factors for hepatocellular carcinoma in the United States , 2016, Cancer.

[47]  T. Pawlik,et al.  Hepatocellular carcinoma: From diagnosis to treatment. , 2016, Surgical oncology.

[48]  Anders Nielsen,et al.  TMB: Automatic Differentiation and Laplace Approximation , 2015, 1509.00660.

[49]  D. Abbott,et al.  Disparities in care for patients with curable hepatocellular carcinoma. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[50]  Mei-Hwei Chang,et al.  Prevention of hepatitis B. , 2015, Cold Spring Harbor perspectives in medicine.

[51]  L. Nguyen,et al.  Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[52]  H. Luma,et al.  The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. , 2014, Journal of hepatology.

[53]  S. J. Henley,et al.  Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States , 2014, The American Journal of Gastroenterology.

[54]  Aijaz Ahmed,et al.  Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians , 2013, Journal of Immigrant and Minority Health.

[55]  S. Altekruse,et al.  Time Trends in Liver Cancer Mortality, Incidence, and Risk Factors by Unemployment Level and Race/Ethnicity, United States, 1969–2011 , 2013, Journal of Community Health.

[56]  Andrew M. Penner,et al.  Cause of Death Affects Racial Classification on Death Certificates , 2011, PloS one.

[57]  J. Dimick,et al.  Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. , 2010, Archives of surgery.

[58]  M. Naghavi,et al.  Algorithms for enhancing public health utility of national causes-of-death data , 2010, Population health metrics.

[59]  S. Bhatia,et al.  Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States , 2010, Cancer.

[60]  G. Davis,et al.  The Healthcare Burden Imposed by Liver Disease in Aging Baby Boomers , 2010, Current gastroenterology reports.

[61]  M. Putt,et al.  Racial/ethnic differences in physician distrust in the United States. , 2007, American journal of public health.

[62]  W. Kim Epidemiology of hepatitis B in the United States , 2007, Hepatology.

[63]  Hegang Chen,et al.  Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. , 2006, Journal of the National Medical Association.

[64]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[65]  S. Asch,et al.  Surgery for Hepatocellular Carcinoma: Does It Improve Survival? , 2004, Annals of Surgical Oncology.

[66]  G. Gores,et al.  Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status , 2003, American Journal of Gastroenterology.

[67]  H. El‐Serag,et al.  Hepatocellular carcinoma. , 2011, The New England journal of medicine.

[68]  H. El‐Serag,et al.  Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study , 2006 .

[69]  P Boffetta,et al.  Socioeconomic differences in cancer incidence and mortality. , 1997, IARC scientific publications.

[70]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.